Models of human core transcriptional regulatory circuitries

Genome Research

Volumn 26, Issue 3, 2016, Pages 385-396

  Saint André, Violaine ^a   Federation, Alexander J ^b   Lin, Charles Y ^b   Abraham, Brian J ^a   Reddy, Jessica ^a,c   Lee, Tong Ihn ^a   Bradner, James E ^b,d   Young, Richard A ^a,c  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; PROTEIN BINDING;

ARTICLE; B LYMPHOCYTE; BREAST CANCER CELL LINE; CONTROLLED STUDY; CORE TRANSCRIPTIONAL REGULATORY CIRCUITRY; DNA BINDING; DNA BINDING MOTIF; DNA SEQUENCE; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HCT116 CELL LINE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; JURKAT CELL LINE; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; ANTIBODY SPECIFICITY; BINDING SITE; CELL LINE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; METABOLISM;

BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMAN EMBRYONIC STEM CELLS; HUMANS; ORGAN SPECIFICITY; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84960349182     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.197590.115     Document Type: Article

References (133)

1. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13:720-731.
2. Alon U. 2007. Network motifs: theory and experimental approaches. Nat Rev Genet 8:450-461.
3. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17:126-140.
4. Bar-Joseph Z, Gerber GK, Lee TI, Rinaldi NJ, Yoo JY, Robert F, Gordon DB, Fraenkel E, Jaakkola TS, Young RA, et al. 2003. Computational discovery of gene modules and regulatory networks. Nat Biotechnol 21:1337-1342.
5. Barnea E, Bergman Y. 2000. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J Biol Chem 275:6608-6619.
6. Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, Shao Z, Canver MC, Smith EC, Pinello L, et al. 2013. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342:253-257.
7. Berger MF, Badis G, Gehrke AR, Talukder S, Philippakis AA, Peña-Castillo L, Alleyne TM, Mnaimneh S, Botvinnik OB, Chan ET, et al. 2008. Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell 133:1266-1276.
8. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, et al. 2010. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 28:1045-1048.
9. Bonasio R, Tu S, Reinberg D. 2010. Molecular signals of epigenetic states. Science 330:612-616.
10. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
11. Buganim Y, Faddah DA, Jaenisch R. 2013. Mechanisms and models of somatic cell reprogramming. Nat Rev Genet 14:427-439.
12. Catena R, Tiveron C, Ronchi A, Porta S, Ferri A, Tatangelo L, Cavallaro M, Favaro R, Ottolenghi S, Reinbold R, et al. 2004. Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol Chem 279:41846-41857.
13. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655.
14. Chapuy B, McKeown MR, Lin CY, Monti S, Roemer MGM, Qi J, Rahl PB, Sun HH, Yeda KT, Doench JG, et al. 2013. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 24:777-790.
15. Cheasley D, Pereira L, Lightowler S, Vincan E, Malaterre J, Ramsay RG. 2011. Myb controls intestinal stem cell genes and self-renewal. Stem Cells 29:2042-2050.
16. Chen X, Vega VB, Ng H-H. 2008. Transcriptional regulatory networks inembryonic stem cells. Cold Spring Harb Symp Quant Biol 73:203-209.
17. Chew J-L, Loh Y-H, Zhang W, Chen X, Tam W-L, Yeap L-S, Li P, Ang Y-S, Lim B, Robson P, et al. 2005. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25:6031-6046.
18. Chia N-Y, Chan Y-S, Feng B, Lu X, Orlov YL, Moreau D, Kumar P, Yang L, Jiang J, Lau M-S, et al. 2010. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468:316-320.
19. Conaway RC, Conaway JW. 2011. Origins and activityof the Mediator complex. Semin Cell Dev Biol 22:729-734.
20. Corradin O, Saiakhova A, Akhtar-Zaidi B, Myeroff L, Willis J, Cowper-Sallari R, Lupien M, Markowitz S, Scacheri PC. 2014. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res 24:1-13.
21. Cowper-Sallari R, Zhang X, Wright JB, Bailey SD, Cole MD, Eeckhoute J, Moore JH, Lupien M. 2012. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 44:1191-1198.
22. Davidson EH. 2010. Emerging properties of animal gene regulatory networks. Nature 468:911-920.
23. De Wit E, Bouwman BAM, Zhu Y, Klous P, Splinter E, Verstegen MJAM, Krijger PHL, Festuccia N, Nora EP, Welling M, et al. 2013. The pluripotent genomein three dimensionsisshaped around pluripotency factors. Nature 501:227-231.
24. Declercq J, Sheshadri P, Verfaillie CM, Kumar A. 2013. Zic3 enhances the generation of mouse induced pluripotent stem cells. Stem Cells Dev 22:2017-2025.
25. Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, Rajagopal N, Xie W, et al. 2015. Chromatin architecture reorganization during stem cell differentiation. Nature 518:331-336.
26. Doulatov S, Vo LT, Chou SS, Kim PG, Arora N, Li H, Hadland BK, Bernstein ID, Collins JJ, Zon LI, et al. 2013. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13:459-470.
27. Dowen JM, Fan ZP, Hnisz D, Ren G, Abraham BJ, Zhang LN, Weintraub AS, Schuijers J, Lee TI, Zhao K, et al. 2014. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 159:374-387.
28. Dutkowski J, Kramer M, Surma MA, Balakrishnan R, Cherry JM, Krogan NJ, Ideker T. 2013. A gene ontology inferred from molecular networks. Nat Biotechnol 31:38-45.
29. Farh K. K.-H., Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJH, Shishkin AA, et al. 2015. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518:337-343.
30. Ferri ALM. 2004. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 131:3805-3819.
31. French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, et al. 2013. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 92:489-503.
32. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan K-K, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, et al. 2012. Architecture of the human regulatory network derived from ENCODE data. Nature 489:91-100.
33. Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM. 2013. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell 52:25-36.
34. Gifford CA, Ziller MJ, Gu H, Trapnell C, Donaghey J, Tsankov A, Shalek AK, Kelley DR, Shishkin AA, Issner R, et al. 2013. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell 153:1149-1163.
35. Graf T, Enver T. 2009. Forcing cells to change lineages. Nature 462:587-594.
36. Graham V, Khudyakov J, Ellis P, Pevny L. 2003. SOX2 functionsto maintain neural progenitor identity. Neuron 39:749-765.
37. Grant CE, Bailey TL, Noble WS. 2011. FIMO: scanning for occurrences of a given motif. Bioinformatics 27:1017-1018.
38. Guo G, Smith A. 2010. A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 137:3185-3192.
39. Hawkins RD, Hon GC, Yang C, Antosiewicz-Bourget JE, Lee LK, Ngo Q-M, Klugman S, Ching KA, Edsall LE, Ye Z, et al. 2011. Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency. Cell Res 21:1393-1409.
40. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell 155:934-947.
41. Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, Bradner JE, Young RA. 2015. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell 58:362-370.
42. Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, et al. 2007. Estrogen receptor α (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39:655-660.
43. Horb ME, Shen CN, Tosh D, Slack JMW. 2003. Experimental conversion of liver to pancreas. Curr Biol 13:105-115.
44. Hume MA, Barrera LA, Gisselbrecht SS, Bulyk ML. 2015. UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res 43:D117-D122.
45. Ieda M, Fu J-D, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386.
46. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582.
47. Jolma A, Yan J, Whitington T, Toivonen J, Nitta KR, Rastas P, Morgunova E, Enge M, Taipale M, Wei G, et al. 2013. DNA-binding specificities of human transcription factors. Cell 152:327-339.
48. Jonsson J, Carlsson L, Edlund T, Edlund H. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-609.
49. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, Van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, et al. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467:430-435.
50. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. 2012. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40:D109-D114.
51. Kemmeren P, Sameith K, Van De Pasch LAL, Benschop JJ, Lenstra TL, Margaritis T, O'Duibhir E, Apweiler E, Van Wageningen S, Ko CW, et al. 2014. Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressors. Cell 157:740-752.
52. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. 2007. The role of site accessibility in microRNA target recognition. Nat Genet 39:1278-1284.
53. Krebs HA. 1940. The citric acid cycle and the Szent-Györgyi cycle in pigeon breast muscle. Biochem J 34:775-779.
54. Kumar RM, Cahan P, Shalek AK, Satija R, Jay Daley Keyser A, Li H, Zhang J, Pardee K, Gennert D, Trombetta JJ, et al. 2014. Deconstructing transcriptional heterogeneity in pluripotent stem cells. Nature 516:56-61.
55. Kunarso G, Chia N-Y, Jeyakani J, Hwang C, Lu X, Chan Y-S, Ng H-H, Bourque G. 2010. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 42:631-634.
56. Kuroda T, Tada M, Kubota H, Kimura H, Hatano S, Suemori H, Nakatsuji N, Tada T. 2005. Octamerand Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25:2475-2485.
57. Kuzmichev AN, Kim S-K, D'Alessio AC, Chenoweth JG, Wittko IM, Campanati L, McKay RD. 2012. Sox2 acts through Sox21 to regulate transcription in pluripotent and differentiated cells. Curr Biol 22:1705-1710.
58. Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, Dastur A, Amzallag A, Ramaswamy S, Tesar B, et al. 2014. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 511:616-620.
59. Lee TI, Young RA. 2013. Transcriptional regulation and its misregulation in disease. Cell 152:1237-1251.
60. Lee TI, Rinaldi NJ, Robert F, Odom DT, Bar-Joseph Z, Gerber GK, Hannett NM, Harbison CT, Thompson CM, Simon I, et al. 2002. Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298:799-804.
61. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M, Wang K, Sumazin P, Kustagi M, Bisikirska BC, et al. 2010. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol 6:377.
62. Levine M, Cattoglio C, Tjian R. 2014. Looping back to leap forward: transcription enters a new era. Cell 157:13-25.
63. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
64. Li Y, Lv Z, He G, Wang J, Zhang X, Lu G, Ren X, Wang F, Zhu X, Ding Y, et al. 2015. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer. Oncotarget 6:9099-9112.
65. Lieu YK, Reddy EP. 2009. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci 106:21689-21694.
66. Lim LS, Loh Y-H, Zhang W, Li Y, Chen X, Wang Y, Bakre M, Ng H-H, Stanton LW. 2007. Zic3is required for maintenanceof pluripotencyin embryonic stem cells. Mol Biol Cell 18:1348-1358.
67. Loft A, Forss I, Siersbæk MS, Schmidt SF, Larsen A-S B, Madsen JGS, Pisani DF, Nielsen R, Aagaard MM, Mathison A, et al. 2015. Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers. Genes Dev 29:7-22.
68. Loh Y-H, Wu Q, Chew J-L, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, et al. 2006. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38:431-440.
69. Lovén J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153:320-334.
70. Lujan E, Chanda S, Ahlenius H, Südhof TC, Wernig M. 2012. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc Natl Acad Sci 109:2527-2532.
71. Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD, Etchin J, Lawton L, Sallan SE, Silverman LB, et al. 2014. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346:1373-1377.
72. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, et al. 2007. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9:625-635.
73. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, Buchman S, Chen C, Chou A, Ienasescu H, et al. 2014. JASPAR 2014:an extensively expanded and updated open-access databaseof transcription factor binding profiles. Nucleic Acids Res 42:D142-D147.
74. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al. 2006. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34:D108-D110.
75. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, et al. 2012. Systematic localization of common disease-associated variation in regulatory DNA. Science 337:1190-1195.
76. Medeiros LA, Dennis LM, Gill ME, Houbaviy H, Markoulaki S, Fu D, White AC, Kirak O, Sharp PA, Page DC, et al. 2011. Mir-290-295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects. Proc Natl Acad Sci 108:14163-14168.
77. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642.
78. Morris SA, Daley GQ. 2013. A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res 23:33-48.
79. Nam Y-J, Lubczyk C, Bhakta M, Zang T, Fernandez-Perez A, McAnally J, Bassel-Duby R, Olson EN, Munshi NV. 2014. Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development 141:4267-4278.
80. Navarro P, Festuccia N, Colby D, Gagliardi A, Mullin NP, Zhang W, Karwacki-Neisius V, Osorno R, Kelly D, Robertson M, et al. 2012. OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells. EMBO J 31:4547-4562.
81. Neph S, Stergachis AB, Reynolds A, Sandstrom R, Borenstein E, Stamatoyannopoulos JA. 2012. Circuitry and dynamics of human transcription factor regulatory networks. Cell 150:1274-1286.
82. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Schöler H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
83. Niwa H, Miyazaki J, Smith AG. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376.
84. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, Habib N, Yosef N, Chang CY, Shay T, et al. 2011. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144:296-309.
85. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al. 2004. Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381.
86. Odom DT, Dowell RD, Jacobsen ES, Nekludova L, Rolfe PA, Danford TW, Gifford DK, Fraenkel E, Bell GI, Young RA. 2006. Core transcriptional regulatory circuitry in human hepatocytes. Mol Syst Biol 2:2006.0017.
87. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F. 2005. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem 280:5307-5317.
88. Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, Davison J, Atkins H, Allan D, Dilworth FJ, Gentleman R, et al. 2011. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J 30:494-509.
89. Parker SCJ, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, Van Bueren KL, Chines PS, Narisu N, Black BL, et al. 2013. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci 110:17921-17926.
90. Peter IS, Faure E, Davidson EH. 2012. Predictive computation of genomic logic processing functions in embryonic development. Proc Natl Acad Sci 109:16434-16442.
91. Pique-Regi R, Degner JF, Pai AA, Gaffney DJ, Gilad Y, Pritchard JK. 2011. Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res 21:447-455.
92. Quintana AM, Zhou YE, Pena JJ, O'Rourke JP, Ness SA. 2011. Dramatic repositioning of c-Myb to different promoters during the cell cycle observed by combining cell sorting with chromatin immunoprecipitation. PLoS One 6:e17362.
93. Rajapakse I, Perlman MD, Scalzo D, Kooperberg C, Groudine M, Kosak ST. 2009. The emergence of lineage-specific chromosomal topologies from coordinate gene regulation. Proc Natl Acad Sci 106:6679-6684.
94. Robasky K, Bulyk ML. 2011. UniPROBE, update 2011:expanded content and search tools in the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res 39:D124-D128.
95. Rodda DJ, Chew J-L, Lim L-H, Loh Y-H, Wang B, Ng H-H, Robson P. 2005. Transcriptional regulation of Nanog by OCT4 and SOX2. J Biol Chem 280:24731-24737.
96. Roeder RG. 2005. Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett 579:909-915.
97. Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, et al. 2014. A proteome-scale map of the human interactome network. Cell 159:1212-1226.
98. Sanda T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A, Ma W, Tatarek J, Ahn Y, Kelliher MA, et al. 2012. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 22:209-221.
99. Schmidt SF, Larsen BD, Loft A, Nielsen R, Madsen JGS, Mandrup S. 2015. Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers. Genome Res 25:1281-1294.
100. Siersbæk R, Baek S, Rabiee A, Nielsen R, Traynor S, Clark N, Sandelin A, Jensen ON, Sung M-H, Hager GL, et al. 2014a. Molecular architecture of transcription factor hotspots in early adipogenesis. Cell Rep 7:1434-1442.
101. Siersbæk R, Rabiee A, Nielsen R, Sidoli S, Traynor S, Loft A, La Cour Poulsen L, Rogowska-Wrzesinska A, Jensen ON, Mandrup S. 2014b. Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep 7:1443-1455.
102. Silva J, Nichols J, Theunissen TW, Guo G, Van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A. 2009. Nanog is the gateway to the pluripotent ground state. Cell 138:722-737.
103. Sisodiya SM, Ragge NK, Cavalleri GL, Hever A, Lorenz B, Schneider A, Williamson KA, Stevens JM, Free SL, Thompson PJ, et al. 2006. Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia 47:534-542.
104. Song K, Nam Y-J, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, et al. 2012. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485:599-604.
105. Spitz F, Furlong EEM. 2012. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13:613-626.
106. Stergachis AB, Neph S, Sandstrom R, Haugen E, Reynolds AP, Zhang M, Byron R, Canfield T, Stelhing-Sun S, Lee K, et al. 2014. Conservation of trans-acting circuitry during mammalian regulatory evolution. Nature 515:365-370.
107. Sur IK, Hallikas O, Vähärautio A, Yan J, Turunen M, Enge M, Taipale M, Karhu A, Aaltonen LA, Taipale J. 2012. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science 338:1360-1363.
108. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
109. Theunissen TW, Van Oosten AL, Castelo-Branco G, Hall J, Smith A, Silva JCR. 2011. Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol 21:65-71.
110. Tomioka M, Nishimoto M, Miyagi S, Katayanagi T, Fukui N, Niwa H, Muramatsu M, Okuda A. 2002. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 30:3202-3213.
111. Tsankov AM, Gu H, Akopian V, Ziller MJ, Donaghey J, Amit I, Gnirke A, Meissner A. 2015. Transcription factor binding dynamics during human ES cell differentiation. Nature 518:344-349.
112. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Björklund M, Wei G, Yan J, Niittymäki I, et al. 2009. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41:885-890.
113. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, et al. 2004. Mutation of GATA3 in human breast tumors. Oncogene 23:7669-7678.
114. Van Den Boogaard M, Wong LYE, Tessadori F, Bakker ML, Dreizehnter LK, Wakker V, Bezzina CR, 't Hoen PAC, Bakkers J, Barnett P, et al. 2012. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest 122:2519-2530.
115. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. 2009. A census of human transcription factors: function, expression and evolution. Nat Rev Genet 10:252-263.
116. Wang W, Yang J, Liu H, Lu D, Chen X, Zenonos Z, Campos LS, Rad R, Guo G, Zhang S, et al. 2011. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor γ and liver receptor homolog 1. Proc Natl Acad Sci 108:18283-18288.
117. Wei G-H, Badis G, Berger MF, Kivioja T, Palin K, Enge M, Bonke M, Jolma A, Varjosalo M, Gehrke AR, et al. 2010. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J 29:2147-2160.
118. White JR, Weston K. 2000. Myb is required for self-renewal in a model system of early hematopoiesis. Oncogene 19:1196-1205.
119. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediatorestablish super-enhancers at key cell identity genes. Cell 153:307-319.
120. Wong N, Wang X. 2015. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 43:D146-D152.
121. Yan J, Enge M, Whitington T, Dave K, Liu J, Sur I, Schmierer B, Jolma A, Kivioja T, Taipale M, et al. 2013. Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites. Cell 154:801-813.
122. Yang H-M, Do H-J, Kim D-K, Park J-K, Chang W-K, Chung H-M, Choi S-Y, Kim J-H. 2007. Transcriptional regulation of human Oct4 by steroidogenic factor-1. J Cell Biochem 101:1198-1209.
123. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A, Wu C, Karwacz K, Xiao S, Jorgolli M, et al. 2013. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496:461-468.
124. Young RA. 2011. Control of the embryonic stem cell state. Cell 144:940-954.
125. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
126. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137.
127. Zhang X, Yalcin S, Lee D-F, Yeh T-Y J, Lee S-M, Su J, Mungamuri SK, Rimmelé P, Kennedy M, Sellers R, et al. 2011. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol 13:1092-1099.
128. Zhong S, He X, Bar-Joseph Z. 2013. Predicting tissue specific transcription factor binding sites. BMC Genomics 14:796.
129. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. 2008. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455:627-632.
130. Zhou Q, Li T, Price DH. 2012. RNA polymerase II elongation control. Annu Rev Biochem 81:119-143.
131. Zhu Y, Richardson JA, Parada LF, Graff JM. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714.
132. Ziller MJ, Edri R, Yaffe Y, Donaghey J, Pop R, Mallard W, Issner R, Gifford CA, Goren A, Xing J, et al. 2014. Dissecting neural differentiation regulatory networks through epigenetic footprinting. Nature 518:355-359.
133. Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, Shi J, Weissmueller S, Fellmann C, Fellman C, et al. 2011. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev 25:1628-1640.